Pharsight

Ionsys patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6881208 THE MEDICINES CO Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
Apr, 2022

(1 year, 5 months ago)

US6975902 THE MEDICINES CO Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof
Apr, 2024

(6 months from now)

US8301238 THE MEDICINES CO Two-part electrotransport device
Sep, 2031

(8 years from now)

US9364656 THE MEDICINES CO Method of storing an electrotransport drug delivery device
Sep, 2031

(8 years from now)

US9731121 THE MEDICINES CO Switch validation circuit and method
Oct, 2031

(8 years from now)

US8781571 THE MEDICINES CO Switch validation circuit and method
Mar, 2032

(8 years from now)

US8428708 THE MEDICINES CO Self-test for analgesic product
May, 2032

(8 years from now)

US8428709 THE MEDICINES CO Current control for electrotransport drug delivery
Jun, 2032

(8 years from now)

US9095706 THE MEDICINES CO Self-test for analgesic product
Feb, 2033

(9 years from now)

Ionsys is owned by The Medicines Co.

Ionsys contains Fentanyl Hydrochloride.

Ionsys has a total of 9 drug patents out of which 1 drug patent has expired.

Expired drug patents of Ionsys are:

  • US6881208

Ionsys was authorised for market use on 22 May, 2006.

Ionsys is available in system;iontophoresis, transdermal dosage forms.

Ionsys can be used as method for iontophoretic transdermal delivery of fentanyl hydrochloride.

The generics of Ionsys are possible to be released after 03 February, 2033.

Drugs and Companies using FENTANYL HYDROCHLORIDE ingredient

Market Authorisation Date: 22 May, 2006

Treatment: Method for iontophoretic transdermal delivery of fentanyl hydrochloride

Dosage: SYSTEM;IONTOPHORESIS, TRANSDERMAL

More Information on Dosage

IONSYS family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic